• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者体内透明质酸的产生与消除:通过负荷试验进行评估

Production and elimination of hyaluronan in rheumatoid arthritis patients: estimation with a loading test.

作者信息

Torsteinsdottir I, Groth T, Lindqvist U

机构信息

Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

出版信息

Semin Arthritis Rheum. 1999 Feb;28(4):268-79. doi: 10.1016/s0049-0172(99)80022-5.

DOI:10.1016/s0049-0172(99)80022-5
PMID:10073501
Abstract

OBJECTIVE

To evaluate the benefit of determining the maximal elimination rate (Vmax) and the endogenous production of hyaluronan (HYA) in relation to the basal HYA concentration (c0) in rheumatoid arthritis (RA) patients; and to evaluate the compatibility of a new model for HYA kinetics, taking renal elimination into separate account in the overall clearance of HYA from the blood.

METHODS

The calculations of production and elimination of HYA were based on the HYA loading test, which was performed in 21 patients with RA and 15 healthy controls. A blood sample was drawn before the loading test, followed by an intravenous (i.v.) injection of HYA as a single bolus dose of 7.5 mg. Blood samples were taken regularly during the next 60 minutes. A theoretical model with computational analysis of the data collected was used for calculating HYA production and elimination.

RESULTS

Patients with RA had significantly higher c0 than healthy controls, although in 10 of 21 patients c0 was within the normal range. The RA patients also had higher Vmax than healthy controls, but the difference was not significant. The calculated production of HYA was increased in RA patients (P = .001) and correlated with c0 (P < .0001). The new model for HYA kinetics, in which the renal elimination was taken separately into account, proved to be more compatible than the previous model.

CONCLUSION

The HYA loading test can help determine whether the increased serum level of HYA in RA patients is due to a high production or reduced elimination of HYA or both.

摘要

目的

评估测定类风湿关节炎(RA)患者的最大清除率(Vmax)和透明质酸(HYA)内源性生成量与基础HYA浓度(c0)的关系的益处;并评估一种新的HYA动力学模型的兼容性,该模型在从血液中清除HYA的总体清除率中单独考虑肾脏清除情况。

方法

HYA生成和清除的计算基于HYA负荷试验,该试验在21例RA患者和15名健康对照者中进行。在负荷试验前采集一份血样,随后静脉注射(i.v.)7.5mg单剂量推注的HYA。在接下来的60分钟内定期采集血样。使用对收集的数据进行计算分析的理论模型来计算HYA的生成和清除。

结果

RA患者的c0显著高于健康对照者,尽管21例患者中有10例的c0在正常范围内。RA患者的Vmax也高于健康对照者,但差异不显著。RA患者中计算出的HYA生成量增加(P = 0.001),且与c0相关(P < 0.0001)。新的HYA动力学模型,其中单独考虑了肾脏清除,被证明比先前的模型更具兼容性。

结论

HYA负荷试验有助于确定RA患者血清HYA水平升高是由于HYA生成量高还是清除减少或两者兼而有之。

相似文献

1
Production and elimination of hyaluronan in rheumatoid arthritis patients: estimation with a loading test.类风湿关节炎患者体内透明质酸的产生与消除:通过负荷试验进行评估
Semin Arthritis Rheum. 1999 Feb;28(4):268-79. doi: 10.1016/s0049-0172(99)80022-5.
2
High pleural fluid hyaluronan concentrations in rheumatoid arthritis.类风湿关节炎中胸腔积液透明质酸浓度较高。
Eur Respir J. 1999 Mar;13(3):519-22. doi: 10.1183/09031936.99.13351999.
3
A hyaluronan-loading test applied to patients with liver and joint diseases.
Clin Chim Acta. 1992 Sep 15;210(1-2):119-32. doi: 10.1016/0009-8981(92)90050-z.
4
Seven different assays of hyaluronan compared for clinical utility.对七种不同的透明质酸检测方法进行了临床实用性比较。
Clin Chem. 1992 Jan;38(1):127-32.
5
Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.新型透明质酸(HYA-JOINT Plus)与施沛特单关节腔内注射治疗膝骨关节炎的比较:一项疗效与安全性的随机、对照、双盲试验
J Bone Joint Surg Am. 2017 Mar 15;99(6):462-471. doi: 10.2106/JBJS.16.00469.
6
Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma.血清中的透明质酸作为产生透明质酸的恶性间皮瘤病情进展的指标。
Cancer. 1999 Nov 15;86(10):2000-5.
7
Preclinical pharmacokinetics of radiolabelled hyaluronan.放射性标记透明质酸的临床前药代动力学。
Pharmacol Rep. 2012;64(2):428-37. doi: 10.1016/s1734-1140(12)70784-3.
8
[Hyaluronan and CD44 in maternal serum in pre-eclampsia].子痫前期孕妇血清中的透明质酸和CD44
Z Geburtshilfe Neonatol. 1999 Nov-Dec;203(6):246-9.
9
Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.多发性骨髓瘤患者的血清透明质酸:与生存率及免疫球蛋白浓度的相关性
Blood. 1999 Jun 15;93(12):4144-8.
10
Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.骨髓纤维化/骨髓硬化综合征及其他骨髓增殖性疾病中的循环透明质酸
Am J Hematol. 1991 Jan;36(1):1-8. doi: 10.1002/ajh.2830360102.